Bramson C[au] - Search Results

Year	Number of Results
2005	3
2006	6
2007	1
2011	1
2012	1
2013	2
2014	1
2015	5
2017	1
2020	1
2022	1

1

Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety.

Markman JD, Bolash RB, McAlindon TE, Kivitz AJ, Pombo-Suarez M, Ohtori S, Roemer FW, Li DJ, Viktrup L, Bramson C, West CR, Verburg KM. Markman JD, et al. Among authors: bramson c. Pain. 2020 Sep 1;161(9):2068-2078. doi: 10.1097/j.pain.0000000000001928. Pain. 2020. PMID: 32453139 Free PMC article. Clinical Trial.

2

Fibromyalgia syndrome.

Mease PJ, Clauw DJ, Arnold LM, Goldenberg DL, Witter J, Williams DA, Simon LS, Strand CV, Bramson C, Martin S, Wright TM, Littman B, Wernicke JF, Gendreau RM, Crofford LJ. Mease PJ, et al. Among authors: bramson c. J Rheumatol. 2005 Nov;32(11):2270-7. J Rheumatol. 2005. PMID: 16265715

3

Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70.

Bergmark BA, Marston NA, Bramson CR, Curto M, Ramos V, Jevne A, Kuder JF, Park JG, Murphy SA, Verma S, Wojakowski W, Terra SG, Sabatine MS, Wiviott SD; TRANSLATE-TIMI 70 Investigators. Bergmark BA, et al. Among authors: bramson cr. Circulation. 2022 May 3;145(18):1377-1386. doi: 10.1161/CIRCULATIONAHA.122.059266. Epub 2022 Apr 3. Circulation. 2022. PMID: 35369705 Free PMC article. Clinical Trial.

4

Characterization of nitrotyrosine as a biomarker for arthritis and joint injury.

Misko TP, Radabaugh MR, Highkin M, Abrams M, Friese O, Gallavan R, Bramson C, Hellio Le Graverand MP, Lohmander LS, Roman D. Misko TP, et al. Among authors: bramson c. Osteoarthritis Cartilage. 2013 Jan;21(1):151-6. doi: 10.1016/j.joca.2012.09.005. Epub 2012 Sep 28. Osteoarthritis Cartilage. 2013. PMID: 23025928 Free article.

5

Effects of ethanol on the pharmacokinetics of extended-release oxycodone with sequestered naltrexone (ALO-02).

Malhotra BK, Matschke K, Wang Q, Bramson C, Salageanu J. Malhotra BK, et al. Among authors: bramson c. Clin Drug Investig. 2015 Apr;35(4):267-74. doi: 10.1007/s40261-015-0278-6. Clin Drug Investig. 2015. PMID: 25724154 Clinical Trial.

6

Exploring the role of tanezumab as a novel treatment for the relief of neuropathic pain.

Bramson C, Herrmann DN, Carey W, Keller D, Brown MT, West CR, Verburg KM, Dyck PJ. Bramson C, et al. Pain Med. 2015 Jun;16(6):1163-76. doi: 10.1111/pme.12677. Epub 2015 Jan 16. Pain Med. 2015. PMID: 25594611 Clinical Trial.

7

Bioavailability of amlodipine besylate/atorvastatin calcium combination tablet.

Chung M, Calcagni A, Glue P, Bramson C. Chung M, et al. Among authors: bramson c. J Clin Pharmacol. 2006 Sep;46(9):1030-7. doi: 10.1177/0091270006291031. J Clin Pharmacol. 2006. PMID: 16920898 Clinical Trial.

8

Long-term safety and effectiveness of tanezumab as treatment for chronic low back pain.

Gimbel JS, Kivitz AJ, Bramson C, Nemeth MA, Keller DS, Brown MT, West CR, Verburg KM. Gimbel JS, et al. Among authors: bramson c. Pain. 2014 Sep;155(9):1793-1801. doi: 10.1016/j.pain.2014.06.004. Epub 2014 Jun 14. Pain. 2014. PMID: 24937440 Clinical Trial.

9

Lack of a pharmacokinetic interaction between azithromycin and chloroquine.

Cook JA, Randinitis EJ, Bramson CR, Wesche DL. Cook JA, et al. Among authors: bramson cr. Am J Trop Med Hyg. 2006 Mar;74(3):407-12. Am J Trop Med Hyg. 2006. PMID: 16525098 Clinical Trial.

10

Effects of lasofoxifene on the pharmacokinetics and pharmacodynamics of single-dose warfarin.

Ouellet D, Bramson C, Carvajal-Gonzalez S, Roman D, Randinitis E, Remmers A, Gardner MJ. Ouellet D, et al. Among authors: bramson c. Br J Clin Pharmacol. 2006 Jun;61(6):741-5. doi: 10.1111/j.1365-2125.2006.02589.x. Br J Clin Pharmacol. 2006. PMID: 16722839 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results